Wave Life Sciences Ltd

Company Profile

Wave Life Sciences Ltd had its IPO on 2015-11-11 under the ticker symbol WVE.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Wave Life Sciences Ltd has a staff strength of 0 employees.

Stock update

Shares of Wave Life Sciences Ltd opened at $4.75 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $4.66 - $5, and closed at $4.84.

This is a +0.62% increase from the previous day's closing price.

A total volume of 136,683 shares were traded at the close of the day’s session.

In the last one week, shares of Wave Life Sciences Ltd have slipped by -3.2%.

Wave Life Sciences Ltd's Key Ratios

Wave Life Sciences Ltd has a market cap of $0.405 billion, indicating a price to book ratio of 12.68 and a price to sales ratio of 10.04.

In the last 12-months Wave Life Sciences Ltd’s revenue was $0.040 billion with a gross profit of $-0.074 billion and an EBITDA of $-0.117 billion. The EBITDA ratio measures Wave Life Sciences Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Wave Life Sciences Ltd’s operating margin was -307.5% while its return on assets stood at -36.9% with a return of equity of -350.5%.

In Q2, Wave Life Sciences Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a negative 86.5%.

Wave Life Sciences Ltd’s PE and PEG Ratio

Forward PE

-

Trailing PE

-

PEG

0

Its diluted EPS in the last 12-months stands at $-2.151 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Wave Life Sciences Ltd’s profitability.

Wave Life Sciences Ltd stock is trading at a EV to sales ratio of 7.04 and a EV to EBITDA ratio of -2.489. Its price to sales ratio in the trailing 12-months stood at 10.04.

Wave Life Sciences Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0.000 billion

Total Liabilities

$0.000 billion

Operating Cash Flow

$0.000 billion

Capital Expenditure

$0.000 billion

Dividend Payout Ratio

0%

Wave Life Sciences Ltd ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Wave Life Sciences Ltd ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Wave Life Sciences Ltd’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Wave Life Sciences Ltd's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Wave Life Sciences Ltd paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price

$4.84

52-Week High

$5.31

52-Week Low

$1.16

Analyst Target Price

$8.29

Wave Life Sciences Ltd stock is currently trading at $4.84 per share. It touched a 52-week high of $5.31 and a 52-week low of $5.31. Analysts tracking the stock have a 12-month average target price of $8.29.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.